What is Ardelyx's R&D?

Ardelyx (ARDX) reported R&D of $20.19M in Q1 2026.

How has Ardelyx's R&D changed year-over-year?

Ardelyx's R&D increased by 35.1% year-over-year, from $14.94M to $20.19M.

What is the long-term trend for Ardelyx's R&D?

Over 4 years (2021 to 2025), Ardelyx's R&D has grown at a -5.9% compound annual growth rate (CAGR), from $91.14M to $71.53M.

Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.

Ardelyx ARDX R&D

R&D at other companies

AmgenAMGN

$1.72B+15.7%

Bausch Health CompaniesBHC

$163M+14.0%

XER

Xeris Biopharma Holdings, Inc.XERS

$8.78M+13.3%

Eton Pharmaceuticals, Inc.ETON

$1.88M+61.5%

Neurocrine BiosciencesNBIX

$296.2M+12.5%

Aurinia PharmaceuticalsAUPH

$7.47M+30.1%

Other financials

Income statement

See full

Revenue$94.5M+27.5%

Gross profit$89.7M+45.1%

Operating income-$32.8M+9.8%

Net income-$37.6M+8.6%

EPS (diluted)-$0.15+11.8%

Balance sheet

See full

Cash & equivalents$31.2M+1.3%

Total debt$208.3M+34.3%

Total equity$148.6M+2.0%

Total assets$504.5M+23.0%

Cash flow

See full

Operating cash flow-$32.2M+16.2%

CapEx$69.0K-78.8%

Free cash flow-$32.3M+16.7%

Valuation

See full

Market cap$1.53B+79.5%

Enterprise value$1.71B+74.8%

P/S3.6×+1.2×

Profitability

See full

Gross margin92.5%+7.9pp

Operating margin-25.4%—

Net margin-13.6%—

FCF margin-40.9%—

Returns & leverage

See full

Return on equity-39.5%—

Debt / equity1.4×+0.3×

Current ratio3.5×-0.6×

Where this comes from

Reported directly by Ardelyx in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: Ardelyx’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ardelyx's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Ardelyx's R&D?: Ardelyx (ARDX) reported R&D of $20.19M in Q1 2026.
How has Ardelyx's R&D changed year-over-year?: Ardelyx's R&D increased by 35.1% year-over-year, from $14.94M to $20.19M.
What is the long-term trend for Ardelyx's R&D?: Over 4 years (2021 to 2025), Ardelyx's R&D has grown at a -5.9% compound annual growth rate (CAGR), from $91.14M to $71.53M.
What does R&D mean?: Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.